Noraramtide, identified by its CAS number 2580150-96-3, is a synthetic chemical compound that belongs to the class of small molecules. It is primarily recognized for its potential therapeutic applications, particularly in the field of oncology. The compound exhibits a unique structure that allows it to interact with specific biological targets, potentially influencing cellular processes such as proliferation and apoptosis. Noraramtide's mechanism of action may involve modulation of signaling pathways, making it a candidate for further research in cancer treatment. Additionally, its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile. As with many investigational drugs, ongoing studies are essential to fully elucidate its characteristics, including its potency, selectivity, and potential side effects. Overall, Noraramtide represents a promising area of study within medicinal chemistry, contributing to the development of novel therapeutic strategies.

Noraramtide

2580150-96-3: Noraramtide, identified by its CAS number 2580150-96-3, is a synthetic chemical compound that belongs to the class of small molecules. It is primarily recognized for its potential therapeutic applications, particularly in the field of oncology. The compound exhibits a unique structure that allows it to interact with specific biological targets, potentially influencing cellular processes such as proliferation and apoptosis. Noraramtide's mechanism of action may involve modulation of signaling pathways, making it a candidate for further research in cancer treatment. Additionally, its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile. As with many investigational drugs, ongoing studies are essential to fully elucidate its characteristics, including its potency, selectivity, and potential side effects. Overall, Noraramtide represents a promising area of study within medicinal chemistry, contributing to the development of novel therapeutic strategies.

<p>Noraramtide (BHV-1100) is an antibody recruiting molecule that specifically binds to the CD38 molecule to recruit natural killer (NK) cells. This interaction enhances the NK cells' ability to kill tumor cells through antibody-dependent cellular cytotoxicity (ADCC). This mechanism allows NK cells to more effectively recognize and eliminate tumor cells while preventing mutual NK cell destruction. Noraramtide is utilized in research on autologous cancer immunotherapy.</p>

CAS 2580150-96-3

Noraramtide

Noraramtide

Ref: TM-TP2750